Your browser doesn't support javascript.
loading
[The antithrombotic jungle: an overview of the recent literature]. / Oerwoud van antitrombotica: een overzicht van recente literatuur.
Geersing, Geert-Jan; Greving, Jacoba P; Folkeringa, Richard; Hemels, Martin E W; Ten Cate, Hugo; Huisman, Menno V.
Afiliação
  • Geersing GJ; UMC Utrecht, Julius Centrum voor Gezondheidswetenschappen en Eerstelijnsgeneeskunde, Utrecht.
  • Greving JP; Contact: G.J. Geersing (g.j.geersing@umcutrecht.nl).
  • Folkeringa R; UMC Utrecht, Julius Centrum voor Gezondheidswetenschappen en Eerstelijnsgeneeskunde, Utrecht.
  • Hemels MEW; Medisch Centrum Leeuwarden, afd. Cardiologie, Leeuwarden.
  • Ten Cate H; Rijnstate, afd. Cardiologie, Arnhem.
  • Huisman MV; Maastricht UMC+, afd. Vasculaire Geneeskunde, Maastricht.
Ned Tijdschr Geneeskd ; 1632019 11 07.
Article em Nl | MEDLINE | ID: mdl-31750636
ABSTRACT
Physicians encounter patients who use antithrombotics in virtually every area of medical specialisation. As antithrombotic use is often chronic, it is important for medication monitoring that physicians have sufficient knowledge of the latest developments, even if they do not prescribe antithrombotics themselves. The risk of thrombosis must be weighed against the risk of bleeding in every patient who is eligible to be treated with antithrombotics. In this article we describe the main indications for treatment with antithrombotics based on articles published within the past five years.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Fibrinolíticos / Hemorragia Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: Nl Ano de publicação: 2019 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombose / Fibrinolíticos / Hemorragia Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: Nl Ano de publicação: 2019 Tipo de documento: Article